A motion for preliminary approval of a class action settlement between Deloitte and the victims of the RIBridges data breach ...

A new study reveals that men with a mutation to the BRCA genes, often known as the ‘Angelina Jolie’ gene because the ...

Condensate formation is central to how budding yeast cells decide their response to environmental and internal conditions ...

Endocrine therapy typically slows cell cycle progression by reducing cyclin D1, which partners with CDK4/6 to promote cell ...

Australia could be a global hub for food tech and biomanufacturing, but only if the government backs the industry through ...

The escape of 75,000 farmed fish from damaged pens in the Highlands could pose a genetic threat to native Atlantic salmon.

A poster titled Updated data from ABOYA-119: A phase 1/2a trial of ATRN-119, a novel macrocyclic ATR inhibitor, in patients with advanced solid tumors harboring DNA damage will be presented at the ...

About Aprea Aprea’s mission is to develop novel cancer therapies that target cancer cells directly, while sparing healthy ones. By exploiting unique vulnerabilities in cancer cell mutations, this ...

The Medicines and Healthcare products Regulatory Agency (MHRA) National Institute for Health and Care Excellence (NICE) Scottish Medicines Consortium (SMC) (on behalf of NHS boards in Scotland) ...

Welcome listeners to Circulation on the Run and the October 14th issue. And I'm one of your co-hosts, Dr. Greg Hundley, associate editor, director of the Pauley Heart Center at VCU Health in Richmond, ...

Developers work with the NHS, the medicines regulator and the UK health technology assessment bodies from the early stages of clinical development, as ...